This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency within the Department of Health and Human Services (HHS), to Emulate Inc., a for-profit small business. The contract, valued at $145,260.00, is for the delivery of Emulate's CHIP-S1 Stretchable Chip, a product in their organ-on-a-chip technology line. This technology supports various FDA and HHS initiatives in areas such as personalized medicine, biosurveillance, infectious disease research, and alternatives to animal testing. The contract has an ultimate completion date of August 31, 2024. Emulate Inc. has received previous federal contract and grant awards, including a cooperative agreement from the Defense Advanced Research Projects Agency (DARPA) for research on advanced organ-on-chip models.
Generated 8/2/24, 9:46 AM